nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzonatate—Numbness—Fludarabine—lymphatic system cancer	0.0551	0.0551	CcSEcCtD
Benzonatate—Sensory loss—Fludarabine—lymphatic system cancer	0.0528	0.0528	CcSEcCtD
Benzonatate—Numbness—Vincristine—lymphatic system cancer	0.0337	0.0337	CcSEcCtD
Benzonatate—Sensory loss—Vincristine—lymphatic system cancer	0.0322	0.0322	CcSEcCtD
Benzonatate—Bronchospasm—Teniposide—lymphatic system cancer	0.0321	0.0321	CcSEcCtD
Benzonatate—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.0282	0.0282	CcSEcCtD
Benzonatate—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.0228	0.0228	CcSEcCtD
Benzonatate—Eruption—Methotrexate—lymphatic system cancer	0.022	0.022	CcSEcCtD
Benzonatate—Agitation—Teniposide—lymphatic system cancer	0.0209	0.0209	CcSEcCtD
Benzonatate—Bronchospasm—Bleomycin—lymphatic system cancer	0.0207	0.0207	CcSEcCtD
Benzonatate—Confusional state—Teniposide—lymphatic system cancer	0.0187	0.0187	CcSEcCtD
Benzonatate—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0185	0.0185	CcSEcCtD
Benzonatate—Agitation—Fludarabine—lymphatic system cancer	0.0184	0.0184	CcSEcCtD
Benzonatate—Pruritus—Mechlorethamine—lymphatic system cancer	0.0178	0.0178	CcSEcCtD
Benzonatate—Convulsion—Fludarabine—lymphatic system cancer	0.0173	0.0173	CcSEcCtD
Benzonatate—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.0167	0.0167	CcSEcCtD
Benzonatate—Confusional state—Fludarabine—lymphatic system cancer	0.0164	0.0164	CcSEcCtD
Benzonatate—Rash—Mechlorethamine—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Benzonatate—Feeling abnormal—Teniposide—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Benzonatate—Nausea—Mechlorethamine—lymphatic system cancer	0.0149	0.0149	CcSEcCtD
Benzonatate—Hypoaesthesia—Carmustine—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Benzonatate—Hypoaesthesia—Vincristine—lymphatic system cancer	0.014	0.014	CcSEcCtD
Benzonatate—Constipation—Fludarabine—lymphatic system cancer	0.0139	0.0139	CcSEcCtD
Benzonatate—Hypersensitivity—Teniposide—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Benzonatate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Benzonatate—Pruritus—Teniposide—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Benzonatate—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Benzonatate—Confusional state—Bleomycin—lymphatic system cancer	0.0121	0.0121	CcSEcCtD
Benzonatate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Benzonatate—Tremor—Carmustine—lymphatic system cancer	0.012	0.012	CcSEcCtD
Benzonatate—Agitation—Carmustine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Benzonatate—Rash—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Benzonatate—Headache—Teniposide—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Benzonatate—Pruritus—Fludarabine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Benzonatate—Agitation—Vincristine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Benzonatate—Convulsion—Carmustine—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Benzonatate—Nausea—Teniposide—lymphatic system cancer	0.011	0.011	CcSEcCtD
Benzonatate—Convulsion—Vincristine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Benzonatate—Confusional state—Carmustine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Benzonatate—Convulsion—Mitoxantrone—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Benzonatate—Rash—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Benzonatate—Headache—Fludarabine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Benzonatate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00985	0.00985	CcSEcCtD
Benzonatate—Confusional state—Mitoxantrone—lymphatic system cancer	0.00978	0.00978	CcSEcCtD
Benzonatate—Nausea—Fludarabine—lymphatic system cancer	0.00969	0.00969	CcSEcCtD
Benzonatate—Shock—Mitoxantrone—lymphatic system cancer	0.00955	0.00955	CcSEcCtD
Benzonatate—Constipation—Carmustine—lymphatic system cancer	0.00892	0.00892	CcSEcCtD
Benzonatate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00881	0.00881	CcSEcCtD
Benzonatate—Feeling abnormal—Carmustine—lymphatic system cancer	0.0086	0.0086	CcSEcCtD
Benzonatate—Constipation—Vincristine—lymphatic system cancer	0.00852	0.00852	CcSEcCtD
Benzonatate—Pruritus—Bleomycin—lymphatic system cancer	0.00846	0.00846	CcSEcCtD
Benzonatate—Constipation—Mitoxantrone—lymphatic system cancer	0.0083	0.0083	CcSEcCtD
Benzonatate—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00815	0.00815	CcSEcCtD
Benzonatate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.008	0.008	CcSEcCtD
Benzonatate—Hypersensitivity—Carmustine—lymphatic system cancer	0.00769	0.00769	CcSEcCtD
Benzonatate—Rash—Bleomycin—lymphatic system cancer	0.00754	0.00754	CcSEcCtD
Benzonatate—Hypersensitivity—Vincristine—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Benzonatate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00715	0.00715	CcSEcCtD
Benzonatate—Nausea—Bleomycin—lymphatic system cancer	0.0071	0.0071	CcSEcCtD
Benzonatate—Dizziness—Carmustine—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Benzonatate—Dizziness—Vincristine—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Benzonatate—Rash—Carmustine—lymphatic system cancer	0.00658	0.00658	CcSEcCtD
Benzonatate—Headache—Carmustine—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Benzonatate—Rash—Vincristine—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Benzonatate—Headache—Vincristine—lymphatic system cancer	0.00624	0.00624	CcSEcCtD
Benzonatate—Nausea—Carmustine—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Benzonatate—Rash—Mitoxantrone—lymphatic system cancer	0.00612	0.00612	CcSEcCtD
Benzonatate—Headache—Mitoxantrone—lymphatic system cancer	0.00608	0.00608	CcSEcCtD
Benzonatate—Nausea—Vincristine—lymphatic system cancer	0.00592	0.00592	CcSEcCtD
Benzonatate—Nausea—Mitoxantrone—lymphatic system cancer	0.00576	0.00576	CcSEcCtD
Benzonatate—Convulsion—Methotrexate—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Benzonatate—Confusional state—Methotrexate—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Benzonatate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Benzonatate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Benzonatate—Pruritus—Methotrexate—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Benzonatate—Dizziness—Methotrexate—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Benzonatate—Rash—Methotrexate—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Benzonatate—Headache—Methotrexate—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Benzonatate—Nausea—Methotrexate—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
